Compare, Analyse Aurobindo Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
AUROBINDO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs830386-   
Low Rs527279-   
Sales per share (Unadj.) Rs333.9114.9-  
Earnings per share (Unadj.) Rs40.4-29.0-  
Cash flow per share (Unadj.) Rs51.8-24.0-  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs237.190.2-  
Shares outstanding (eoy) m585.91168.78-   
Bonus / Rights / Conversions ESOP--  
Price / Sales ratio x2.02.9 70.2%   
Avg P/E ratio x16.8-11.5 -146.4%  
P/CF ratio (eoy) x13.1-13.9 -94.6%  
Price / Book Value ratio x2.93.7 77.6%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m397,56956,135 708.2%   
No. of employees `00017.94.3 415.9%   
Total wages/salary Rs m25,8493,523 733.7%   
Avg. sales/employee Rs Th10,956.94,519.3 242.4%   
Avg. wages/employee Rs Th1,447.7820.7 176.4%   
Avg. net profit/employee Rs Th1,324.3-1,138.8 -116.3%   
INCOME DATA
Net Sales Rs m195,63619,401 1,008.4%  
Other income Rs m1,553136 1,143.2%   
Total revenues Rs m197,18919,537 1,009.3%   
Gross profit Rs m39,519-3,362 -1,175.4%  
Depreciation Rs m6,680837 797.7%   
Interest Rs m2,626526 499.7%   
Profit before tax Rs m31,767-4,589 -692.2%   
Minority Interest Rs m27-13 -211.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269287 2,534.8%   
Profit after tax Rs m23,645-4,889 -483.7%  
Gross profit margin %20.2-17.3 -116.6%  
Effective tax rate %22.9-6.2 -366.2%   
Net profit margin %12.1-25.2 -48.0%  
BALANCE SHEET DATA
Current assets Rs m153,64514,210 1,081.3%   
Current liabilities Rs m120,4297,995 1,506.3%   
Net working cap to sales %17.032.0 53.0%  
Current ratio x1.31.8 71.8%  
Inventory Days Days135111 121.9%  
Debtors Days Days64124 51.4%  
Net fixed assets Rs m103,9098,283 1,254.5%   
Share capital Rs m58690 650.4%   
"Free" reserves Rs m138,3220-   
Net worth Rs m138,90815,228 912.2%   
Long term debt Rs m1,8005,351 33.6%   
Total assets Rs m264,54428,767 919.6%  
Interest coverage x13.1-7.7 -169.4%   
Debt to equity ratio x00.4 3.7%  
Sales to assets ratio x0.70.7 109.7%   
Return on assets %9.9-15.2 -65.5%  
Return on equity %17.0-32.1 -53.0%  
Return on capital %23.8-19.8 -120.3%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Net fx Rs m56,7270-   
CASH FLOW
From Operations Rs m16,2201,656 979.5%  
From Investments Rs m-28,768-508 5,657.7%  
From Financial Activity Rs m19,1914,857 395.1%  
Net Cashflow Rs m6,6566,004 110.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.33 Rs / ZAR

Compare AUROBINDO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: TORRENT PHARMA  PANACEA BIOTECH  JUBILANT PHARMOVA   SHASUN PHARMA  WYETH  



Today's Market

Sensex, Nifty Recover from Day's Low to End Marginally Higher; Divi's Lab & Tata Motors Top Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Related Views On News

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

Don't Break These 5 Intraday Trading Rules (Fast Profits Daily)

Jun 1, 2021

To become a better intraday trader, follow these rules religiously.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Rs 2 Trillion Stimulus Coming to a Stock Market Near You (Profit Hunter)

Jun 2, 2021

Get ready to profit from a massive stimulus that you've never seen before.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


Jun 14, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS